NeonMind Biosciences Inc AI Stock Analysis
Want to see TSE:LCR full AI Analyst Report?
NeonMind Biosciences Inc (LCR) AI Stock Analysis
NeonMind Biosciences Inc
(CNQX:LCR)
The score is primarily constrained by weak financial performance: no revenue, ongoing losses, negative equity, and continued cash burn. Technical indicators also lean bearish with the price below major moving averages and a negative MACD, while valuation is difficult to support given negative earnings and no dividend yield provided.
NeonMind Biosciences Inc (LCR) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 1.09M
- Dividend Yield
- ―
- Average Volume (3M)
- 173.27K
- Price to Earnings (P/E)
- -0.9
- Beta (1Y)
- 1.31
- Revenue Growth
- ―
- EPS Growth
- 57.03%
- Country
- Canada
- Employees
- 0
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Industrial Materials
NeonMind Biosciences Inc Business Overview & Revenue Model
Company Description
Lancaster Resources Inc. focuses on acquiring, exploring, and advancing both mineral deposits and sustainable energy initiatives. A notable asset for the company is its exclusive right to acquire full ownership of the Alkali Flat lithium brine projec...
NeonMind Biosciences Inc Financial Statement Overview
Summary
Income statement quality is very weak with zero reported revenue and persistent operating and net losses across all periods. The balance sheet shows negative shareholders’ equity (a major solvency/financing risk) and debt that is large relative to assets. Cash flow remains negative with ongoing free cash flow burn, though the burn rate has improved versus prior years.
Income Statement
6Very NegativeBalance Sheet
8Very NegativeCash Flow
12Very Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Mar 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -1.02M | -1.58M | 403.40K | ― | -1.75M | -7.83M |
| Net Income | -1.28M | -1.75M | -1.54M | ― | -2.03M | -7.21M |
Balance Sheet | ||||||
| Total Assets | 983.11K | 1.09M | 91.12K | 719.33K | 129.43K | 1.34M |
| Cash, Cash Equivalents and Short-Term Investments | 33.82K | 206.03K | 13.98K | 135.40K | 69.91K | 967.27K |
| Total Debt | 1.10M | 1.14M | 1.19M | 1.04M | 846.94K | 450.01K |
| Total Liabilities | 1.98M | 1.74M | 2.00M | 1.33M | 1.53M | 1.05M |
| Stockholders Equity | -967.66K | -635.18K | -1.90M | -612.89K | -1.40M | 290.30K |
Cash Flow | ||||||
| Free Cash Flow | -794.51K | -988.65K | -89.79K | -1.31M | -1.22M | -5.82M |
| Operating Cash Flow | -794.52K | -988.66K | -89.79K | -1.13M | -1.08M | -5.82M |
| Investing Cash Flow | -258.20K | -129.42K | 37.60K | -36.15K | 72.14K | 389.12K |
| Financing Cash Flow | 1.06M | 1.29M | 0 | 627.93K | 271.00K | 6.20M |
NeonMind Biosciences Inc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LCR, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 32.78 is Neutral, neither overbought nor oversold. The STOCH value of is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LCR.
NeonMind Biosciences Inc Peers Comparison
Overall Rating
- TSE:LCR43Neutral
TSE:LEXT39Underperform
Financial Indicators
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:LCR | NeonMind Biosciences Inc | 0.01 | -0.03 | -75.00% | |
| TSE:LSD.H | Lightspeed Discoveries Inc. | 0.04 | 0.01 | 40.00% | |
| TSE:LEXT | Lexston Life Sciences Corp. | 0.04 | -0.29 | -87.88% |
NeonMind Biosciences Inc Corporate Events
Lancaster Resources Shifts to Semi-Annual Reporting as It Launches Strategic Review
NegativeLancaster Resources Inc. has adopted semi-annual financial reporting under a Canadian securities regulators’ pilot program, easing the administrative and financial burden of quarterly filings while maintaining annual and mid-year statements and conti...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026